Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 30 of 30

Type	Event	Organ system	Group	Affected	At risk
other	Hyperkalaemia	Metabolism and nutrition disorders	Tolvaptan	2	60
other	Hypokalaemia	Metabolism and nutrition disorders	Tolvaptan	1	60
other	Polydipsia	Metabolism and nutrition disorders	Tolvaptan	1	60
other	Dizziness	Nervous system disorders	Tolvaptan	1	60
other	Headache	Nervous system disorders	Tolvaptan	1	60
other	Renal impairment	Renal and urinary disorders	Tolvaptan	1	60
other	Pruritus	Skin and subcutaneous tissue disorders	Tolvaptan	1	60
other	Rash	Skin and subcutaneous tissue disorders	Tolvaptan	1	60
other	Skin exfoliation	Skin and subcutaneous tissue disorders	Tolvaptan	1	60
serious	Cardiac failure chronic	Cardiac disorders	Tolvaptan	1	60

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03255226/events?page=2